Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/896747/000114420417042918/v472652_10q.htm
SEC Filings
ABMC Annual Reports
ABMC Quarterly Reports
10-Q Quarterly Report November 2022
10-Q Quarterly Report August 2022
10-Q Quarterly Report May 2022
10-Q Quarterly Report November 2021
10-Q Quarterly Report August 2021
10-Q Quarterly Report May 2021
10-Q Quarterly Report November 2020
10-Q Quarterly Report September 2020
10-Q Quarterly Report July 2020
10-Q Quarterly Report November 2019
10-Q Quarterly Report November 2022
10-Q Quarterly Report August 2022
10-Q Quarterly Report May 2022
10-Q Quarterly Report November 2021
10-Q Quarterly Report August 2021
10-Q Quarterly Report May 2021
10-Q Quarterly Report November 2020
10-Q Quarterly Report September 2020
10-Q Quarterly Report July 2020
10-Q Quarterly Report November 2019
ABMC Corporate News
Change in Assets
Event for Officers March 2023
Vote of Security Holders February 2023
Financial Exhibit
New Agreement December 2022
Vote of Security Holders June 2022
New Agreement March 2022
Accountant Change
Financial Exhibit December 2021
Earnings Release
Financial Exhibit November 2021
Financial Exhibit
New Agreement October 2021
Earnings Release
Financial Exhibit August 2021
Vote of Security Holders June 2021
Change in Assets
Event for Officers
Event for Officers
March 2023
Vote of Security Holders
February 2023
Financial Exhibit
New Agreement
New Agreement
December 2022
Vote of Security Holders
June 2022
New Agreement
March 2022
Accountant Change
Financial Exhibit
Financial Exhibit
December 2021
Earnings Release
Financial Exhibit
Financial Exhibit
November 2021
Financial Exhibit
New Agreement
New Agreement
October 2021
Earnings Release
Financial Exhibit
Financial Exhibit
August 2021
Vote of Security Holders
June 2021
ABMC Registration of Securities
Last10K.com | 10-Q Quarterly Report Mon Aug 14 2017
Document And Entity Information - shares | 6 Months Ended | |
|---|---|---|
Jun. 30, 2017 | Aug. 14, 2017 | |
| Document Information [Line Items] | ||
| Document Type | 10-Q | |
| Amendment Flag | false | |
| Document Period End Date | Jun. 30, 2017 | |
| Document Fiscal Year Focus | 2017 | |
| Document Fiscal Period Focus | Q2 | |
| Entity Registrant Name | AMERICAN BIO MEDICA CORP | |
| Entity Central Index Key | 0000896747 | |
| Current Fiscal Year End Date | --12-31 | |
| Entity Filer Category | Smaller Reporting Company | |
| Trading Symbol | ABMC | |
| Entity Common Stock, Shares Outstanding | 29,297,333 |
View differences made from one quarter to another to evaluate American Bio Medica Corp's financial trajectory
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by American Bio Medica Corp.
Assess how American Bio Medica Corp's management team is paid from their Annual Proxy
American Bio Medica Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
SEC Filing Tools
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Document And Entity Information
Condensed Balance Sheets
Condensed Balance Sheets (parenthetical)
Condensed Statements Of Cash Flows
Condensed Statements Of Operations
Basis Of Reporting
Basis Of Reporting (details Textual)
Basis Of Reporting (policies)
Inventory
Inventory (details)
Inventory (tables)
Line Of Credit And Debt
Line Of Credit And Debt (details Textual)
Line Of Credit And Debt (details)
Line Of Credit And Debt (tables)
Line Of Credit And Debt - Line Of Credit With Crestmark Bank ("crestmark") (details Textual)
Line Of Credit And Debt - Loan And Security Agreement With Cherokee Financial, Llc (details Textual)
Litigation/legal Matters
Net Loss Per Common Share
Net Loss Per Common Share (details Textual)
Net Loss Per Common Share (details)
Net Loss Per Common Share (tables)
Stock Options And Warrants
Stock Options And Warrants (details 1)
Stock Options And Warrants (details 2)
Stock Options And Warrants (details Textual)
Stock Options And Warrants (details)
Stock Options And Warrants (tables)
Subsequent Event
Subsequent Event (details Texual)
Material Contracts, Statements, Certifications & more
American Bio Medica Corp provided additional information to their SEC Filing as exhibits
Ticker: ABMC
CIK: 896747
Form Type: 10-Q Quarterly Report
Accession Number: 0001144204-17-042918
Submitted to the SEC: Mon Aug 14 2017 12:38:20 PM EST
Accepted by the SEC: Mon Aug 14 2017
Period: Friday, June 30, 2017
Industry: Pharmaceutical Preparations
External Resources:
Stock Quote
Social Media
SEC.gov
Bookmark the Permalink: https://last10k.com/sec-filings/abmc/0001144204-17-042918.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Excel DownloadLoading SEC Filing Financial Summary...